Nomura Holdings, Inc., an investment bank, has appointed Todd Sandoz as global head of execution services and equity trading. Based in London, Mr Sandoz will report to Steve Ashley, Head of Global Markets, and Naoki Matsuba, co-Head of Global ... Individual.com, 1 month ago
3 images for "sandoz inc"
Allergan, Inc., a specialty pharmaceutical company, has received favorable ruling in a patent infringement suit against Sandoz Inc., Lupin Ltd., Lupin Pharmaceuticals Inc., Hi-Tech Pharmacal Co., Inc., Watson Laboratories, Inc., Watson ...Individual.com, 1 month ago Allergan, Inc. : Fish & Richardson Wins Patent Infringement Suit for Allergan Over Generic LUMIGAN® 0.01% 4 Traders, 1 month ago Fish & Richardson Wins Patent Infringement Suit for Allergan Over Generic LUMIGAN® 0.01% Barchart, 1 month ago Fish & Richardson Triumphs in Patent Infringement Suit for Allergan over Generic Lumigan 0.01% [Professional Services Close - Up] Pharmacy Choice, 1 month ago
Allergan Inc. Novartis AG (NOVN)'s Sandoz unit, Actavis Plc, Hi-Tech Pharmacal Co. and Lupin Ltd. (LPC) would infringe Allergan's patents on the medicine, U.S. District Judge Michael Schneider in Tyler, Texas, said in an opinion posted on the ...BusinessWeek, 1 month ago
- Sandoz Canada Inc., in consultation with Health Canada, is voluntarily recalling one lot of its health product, glimepiride that is used to treat diabetes, due to the mislabelling of boxes. While the outer carton of the product is labelled as ...4 Traders, 1 month ago
FEATURED COMPANIES 3 SBio Inc. Bioton Dr.Reddy's Labs (DRL) Hospira Ratiopharm GmbH Sandoz GmbH MORE The global biosimilars market is at a crucial turning point, as ...Research and Markets, 1 week ago Global EPO Biosimilars Market Outlook 2018 Research and Markets, 1 week ago Antibacterial Drugs: World Industry and Market Prospects 2014-2024 ADVFN India, 4 hours ago Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2014-2024 Yahoo! Finance, 1 week ago
(GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ( APRI ) announced today that it will host a conference call on Monday, March 17, 2014, at 5:00 p.m. ET to discuss recent corporate highlights and its fourth quarter and year-end 2013 financial results. ...Yahoo! Finance, 1 day ago Apricus Biosciences Announces Appointment of Wendell Wierenga, Ph.D., to Board of Directors FirstWord Pharma, 1 day ago APRICUS BIOSCIENCES INC : Apricus Biosciences Announces Appointment of Wendell Wierenga, Ph.D., to Board of Directors 4 Traders, 1 day ago Apricus Biosciences to Present at the 26th Annual ROTH Conference Noodls, 1 week ago
(Editor's Note: This article covers a stock trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.) Eagle Pharmaceuticals, Inc., a specialty pharmaceutical ...Seeking Alpha, 2 weeks ago IPO Report: Eagle Pharmaceuticals (EGRX) Equities.com, 3 weeks ago IPO Preview: Eagle Pharmaceuticals Seeking Alpha, 3 weeks ago
Apricus Biosciences, Inc., a developer of NexACT drug delivery technology, has received national phase approval from Belgium's Ministry of Social Affairs, Public Health and Environment for Vitaros, indicated for the treatment of patients with ...Individual.com, 1 month ago Apricus receives Belgium approval for Vitaros to treat erectile dysfunction PharmaBiz, 1 month ago
Sandoz, a generic pharmaceutical division of Novartis, has launched doxercalciferol injection vials, the first generic version of Genzyme's Hectorol, in US. Doxercalciferol injection vials are indicated for the treatment of secondary ...Individual.com, 3 weeks ago
ACTAVIS PLC - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
In prior periods, our consolidated financial statements present the accounts of Actavis, Inc., and all of its wholly-owned subsidiaries. On May 16, 2013, Actavis plc (formally known as Actavis Limited) was incorporated in Ireland as a private ...TMC Net, 2 weeks ago HOSPIRA INC - 10-K - Management's Discussion and Analysis of Financial Condition and Results of Operations TMC Net, 3 weeks ago UNITED THERAPEUTICS CORP - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS TMC Net, 2 weeks ago MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINA. . . Equities.com, 1 month ago
on your WebpageAdd Widget >Get your members hooked!